Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: Cross sectional analysis of the LuLa cohort.
Lupus
Outcome
SLE
delay
diagnosis
Journal
Lupus
ISSN: 1477-0962
Titre abrégé: Lupus
Pays: England
ID NLM: 9204265
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
pubmed:
7
1
2021
medline:
16
10
2021
entrez:
6
1
2021
Statut:
ppublish
Résumé
Despite increased physician's awareness and improved diagnostic and serological testing in the recent years, the interval between the initial symptoms and the diagnosis of Systemic lupus erythematosus (SLE) is still very long. Our aim was to study this delay and its association to the outcome of the disease. Information on demographics, onset of first symptoms, first physicians visit and time of diagnosis was assessed by self-reported questionnaires among SLE patients in Germany (LuLa cohort, n = 585) in the year 2012. Disease activity (Systemic Lupus Activity Questionnaire; SLAQ), disease related damage (Brief Index of Lupus Damage; BILD), health related quality of life (Short Form 12) and fatigue (FSS) were chosen as proxies for outcome. Linear regression analysis was used to analyze the association of the delay in diagnosis to the outcome, adjusted for age, disease duration and sex. Mean duration between the onset of symptoms and the diagnosis of SLE was 47 months (SD 73). The longer the time to diagnosis, the higher the disease activity (β = 0.199, p < 0.0001), the disease-related damage (β = 0.137, p = 0.002) and fatigue (β 0.145, p = 0.003) and the lower the health-related quality of life (physical β = -0.136, p = 0.004, mental β = -0.143, p = 0.004). In systemic lupus erythematosus, longer time to diagnosis was associated with worse outcome. Concepts in care with the intention to shorten the time to diagnosis are needed to improve the long-term outcome of the disease.
Identifiants
pubmed: 33402036
doi: 10.1177/0961203320983445
pmc: PMC7933718
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
431-438Références
Appl Health Econ Health Policy. 2014 Apr;12(2):179-90
pubmed: 24573911
Rheumatol Adv Pract. 2020 Feb 26;4(1):rkaa006
pubmed: 32373774
Lupus. 2017 Sep;26(10):1095-1100
pubmed: 28406053
Lupus. 2020 Feb;29(2):136-143
pubmed: 31992161
Support Care Cancer. 2018 Oct;26(10):3397-3404
pubmed: 29663137
Arthritis Care Res (Hoboken). 2017 Jun;69(6):833-841
pubmed: 27588834
Lupus. 2003;12(4):280-6
pubmed: 12729051
Am J Med Sci. 2010 Jun;339(6):525-31
pubmed: 20400889
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
J Pers Soc Psychol. 1988 Apr;54(4):569-79
pubmed: 3367280
Lupus. 2018 Apr;27(4):681-687
pubmed: 29310537
Arch Neurol. 1989 Oct;46(10):1121-3
pubmed: 2803071
Acta Med Okayama. 2003 Aug;57(4):187-90
pubmed: 14627070
Lupus Sci Med. 2015 Nov 12;2(1):e000113
pubmed: 26629351
Arthritis Care Res (Hoboken). 2011 Aug;63(8):1170-7
pubmed: 21584946
Lupus. 2013 Sep;22(10):1050-5
pubmed: 23963433
Am J Med. 2001 Oct 15;111(6):446-51
pubmed: 11690569
Ann Rheum Dis. 2015 Sep;74(9):1706-13
pubmed: 24834926
Arthritis Care Res (Hoboken). 2010 Jun;62(6):873-80
pubmed: 20191478
Ann Rheum Dis. 2008 Feb;67(2):195-205
pubmed: 17504841
Presse Med. 2014 Jun;43(6 Pt 2):e197-207
pubmed: 24791601
Rheumatology (Oxford). 2019 Jun 1;58(6):987-996
pubmed: 30597077
Z Rheumatol. 2005 Mar;64(2):111-22
pubmed: 15793677
Arthritis Care Res (Hoboken). 2010 Feb;62(2):266-73
pubmed: 20191527
Clin Exp Rheumatol. 2015 May-Jun;33(3):354-9
pubmed: 25797042
Lupus. 2019 Sep;28(10):1189-1196
pubmed: 31307256
Ann Rheum Dis. 2015 Jun;74(6):1045-50
pubmed: 24525911